Bayer AG (BAYGn.DE)

BAYGn.DE on Xetra

95.41EUR
15 Aug 2014
Price Change (% chg)

€-2.28 (-2.33%)
Prev Close
€97.69
Open
€97.78
Day's High
€98.45
Day's Low
€95.03
Volume
2,510,992
Avg. Vol
1,827,017
52-wk High
€114.20
52-wk Low
€83.72

BAYGn.DE

Chart for BAYGn.DE

About

Bayer AG is a German holding company active in the field of health care, nutrition and high-tech materials. It has three business subgroups: HealthCare, involved in the research, development and manufacture of health products for people and animals, CropScience, engaged in the crop protection and non-agricultural pest control,... (more)

Overall

Beta: 0.90
Market Cap (Mil.): €90,137.31
Shares Outstanding (Mil.): 826.95
Dividend: 2.10
Yield (%): 1.93

Financials

  BAYGn.DE Industry Sector
P/E (TTM): 25.29 33.26 33.98
EPS (TTM): 4.31 -- --
ROI: 9.08 18.14 17.39
ROE: 18.35 18.84 18.24
Search Stocks

Bayer names Frank Lutz as MaterialScience CFO

FRANKFURT, Sept 23 - Germany's Bayer named Frank Lutz as chief financial officer of its plastics unit MaterialScience, which it plans to float on the stock market as a separate company.

23 Sep 2014

Bayer asks Rothschild to advise on plastics business flotation: sources

FRANKFURT/LONDON - Bayer has appointed investment bank Rothschild [ROT.UL] to advise on the German drugmaker's plan to list its plastics business, in a deal that could value the unit at about 10 billion euros ($13 billion), sources familiar with the situation said.

22 Sep 2014

Bayer asks Rothschild to advise on plastics business flotation-sources

FRANKFURT/LONDON, Sept 22 - Bayer has appointed investment bank Rothschild to advise on the German drugmaker's plan to list its plastics business, in a deal that could value the unit at about 10 billion euros ($13 bln), sources familiar with the situation said.

22 Sep 2014

BRIEF-Bayer says receives approval for Eylea in Japan

Sept 22 - Bayer AG : * Says receives approval for eylea for the treatment of myopic choroidal

22 Sep 2014

Bayer hits record high on move to list plastics business

FRANKFURT - Germany's Bayer plans to list its plastics business on the stock market in a deal that could value the division at about 10 billion euros ($13 billion) and allow the group to focus on its more profitable life-science businesses. | Video

18 Sep 2014

Bayer eyes MaterialScience float in 12-18 months

FRANKFURT - German drugmaker Bayer said on Thursday the planned flotation of its plastics unit Bayer MaterialScience would take place over the next 12-18 months.

18 Sep 2014

Bayer eyes MaterialScience float in 12-18 months

FRANKFURT, Sept 18 - German drugmaker Bayer said on Thursday the planned flotation of its plastics unit Bayer MaterialScience would take place over the next 12-18 months.

18 Sep 2014

BRIEF-Bayer seen up 2.3 pct after plastics spin-off report

Sept 18 - Bayer AG : * Shares indicated up 2.3 percent after report it plans to separate its

18 Sep 2014

Bayer plans board meeting Thursday morning -source

FRANKFURT, Sept 18 - Germany's Bayer will hold a supervisory board meeting on Thursday morning, a source with knowledge of the matter said following a report it planned to separate its plastics business.

18 Sep 2014

Bayer to unveil plan to sell plastics business: WSJ Deutschland

FRANKFURT - Bayer plans to sell its plastics business with an estimated value of about 8 billion euros ($10.3 billion) as part of a shift away from chemicals toward pharmaceuticals and crop science, a German newspaper reported, citing informed sources.

17 Sep 2014

Earnings vs. Estimates

Search Stocks